Clinical Trials Browser

Phase 2 × Neoplasms, Plasma Cell × Blood Component Removal × Clear all

NCT01174082 2018-06-01

Trial of ID-Specific Donor Vaccinated Lymphocyte Infusion for Patients With Myeloma Relapsing or Failing to Achieve a Complete Remission After an Allogenic Transplant

Phase 2 Terminated

2 enrolled 7 charts

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00968396 2013-04-05

Ex-Vivo Depletion of Myeloma Cells From Peripheral Blood Progenitor Cell Grafts

Phase 2 Withdrawn

Multiple Myeloma, Neoplasms, Plasma Cell